Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-249822
Filing Date
2024-11-01
Accepted
2024-11-01 16:07:52
Documents
3
Group Members
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d885877dsc13ga.htm SC 13G/A 76166
2 EX-99.A d885877dex99a.htm EX-99.A 25424
3 EX-99.B d885877dex99b.htm EX-99.B 836
  Complete submission text file 0001193125-24-249822.txt   104113
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 241419133
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G/A